Trial · NCT01629563
Adverse events90
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 90
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | headache | Nervous system disorders | Ulipristal Acetate (PGL4001) 5mg | 31 | 230 | |
| other | headache | Nervous system disorders | Ulipristal Acetate (PGL4001) 10mg | 30 | 221 | |
| other | hot flush | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 5mg | 18 | 230 | |
| other | hot flush | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 10mg | 23 | 221 | |
| other | influenza | Infections and infestations | Ulipristal Acetate (PGL4001) 5mg | 12 | 230 | |
| other | influenza | Infections and infestations | Ulipristal Acetate (PGL4001) 10mg | 10 | 221 | |
| other | nasopharyngitis | Infections and infestations | Ulipristal Acetate (PGL4001) 5mg | 7 | 230 | |
| other | nasopharyngitis | Infections and infestations | Ulipristal Acetate (PGL4001) 10mg | 12 | 221 | |
| other | breast pain/breast tenderness/breast disconfort | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 5mg | 10 | 230 | |
| other | breast pain/breast tenderness/breast disconfort | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 10mg | 8 | 221 | |
| other | pelvic pain | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 5mg | 10 | 230 | |
| other | pelvic pain | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 10mg | 5 | 221 | |
| other | fatigue | General disorders | Ulipristal Acetate (PGL4001) 5mg | 7 | 230 | |
| other | fatigue | General disorders | Ulipristal Acetate (PGL4001) 10mg | 8 | 221 | |
| other | nausea | Gastrointestinal disorders | Ulipristal Acetate (PGL4001) 5mg | 8 | 230 | |
| other | nausea | Gastrointestinal disorders | Ulipristal Acetate (PGL4001) 10mg | 6 | 221 | |
| other | vaginal discharge | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 5mg | 5 | 230 | |
| other | vaginal discharge | Reproductive system and breast disorders | Ulipristal Acetate (PGL4001) 10mg | 7 | 221 | |
| other | back pain | Musculoskeletal and connective tissue disorders | Ulipristal Acetate (PGL4001) 5mg | 5 | 230 | |
| other | back pain | Musculoskeletal and connective tissue disorders | Ulipristal Acetate (PGL4001) 10mg | 6 | 221 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01629563/events